IP Library › Granted Patent US 12,279,899
Granted Patent B2
US 12,279,899 · App. 17/604,060 · Granted Apr 22, 2025

Sterilizable cover

Inventors: Robert Evans Foster (Birmingham, AL); Lloyd Guyton Bowers Cooper (Birmingham, AL); William Thomas Livingston (Birmingham, AL); Foster D Phillips (Birmingham, AL)
Assignee: RAMPART IC, LLC
A61B6/107G21F3/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,279,899
App. No.
17/604,060
Granted
Apr 22, 2025
Kind
B2
Abstract

A radiation shield assembly is described, configured to block radiation emanating from a radiation source from reaching a user. Two shields are supported by a support arm, and are configured to rotate and translate relative to one another about the support arm's longitudinal axis. This allows the shield to be easily configured and reconfigured as necessary to visualize various parts of a patient's body via radiography. Sterile coverings are provided to ensure asepsis during a surgical procedure.

Claims (100)

1. A radiation shield assembly, configured to block radiation emanating from a radiation source from below a table for supporting a patient, the assembly comprising:

(a) a support arm constructed to support at least the majority of the weight of the shield assembly;

(b) a first generally planar vertical shield; and

(c) a second generally planar vertical shield;

(d) at least one of: (i) a first sterile covering on the first generally planar vertical shield; and (ii) a second sterile covering on the second generally planar vertical shield;

wherein the first generally planar vertical shield is joined to the second generally planar vertical shield to form a radiopaque barrier;

wherein the radiation shield assembly is configured to allow at least one of the first generally planar vertical shield and the second generally planar vertical shield to be rotated relative to the other about an approximately vertical axis; and

wherein the radiation shield assembly is configured to position the first generally planar vertical shield and the second generally planar vertical shield to protect a user's upper body from radiation emanating from the radiation source.

2. The radiation shield assembly of claim 1 , wherein the first generally planar vertical shield is configured to be positioned such that a top edge of the first generally planar vertical shield is at least 175 cm (±20%) from the floor.

3. The radiation assembly of claim 1 , wherein the first generally planar vertical shield is configured to be positioned such that a top edge of the first generally planar vertical shield is at least about the height of an adult human above the floor.

4. The radiation assembly of claim 1 , wherein the first generally planar vertical shield has a height of at least about the distance from the upper surface of the table to an average human's full height.

5. The radiation assembly of claim 1 , wherein the first generally planar vertical shield is fastened to the support arm and the second generally planar vertical shield is fastened to the support arm.

6. The radiation assembly of claim 1 , wherein the support arm is configured to translate the radiation shield assembly relative to the table.

7. The radiation assembly of claim 1 , wherein the support arm is supported from overhead.

8. The radiation assembly of claim 1 , wherein in operation the support arm supports the entire weight of the radiation shield assembly.

9. The radiation assembly of claim 1 , wherein at least one of the first generally planar vertical shield and the second generally planar vertical shield are configured to translate along the support arm.

10. The radiation assembly of claim 1 , configured to position the first generally planar vertical shield and the second generally planar vertical shield to protect the user's head from radiation emanating from the radiation source.

11. The radiation assembly of claim 1 , wherein at least one of the first generally planar vertical shield and the second generally planar vertical shield is configured to translate along the support arm.

12. The radiation assembly of claim 1 , wherein the support arm is configured to position the first generally planar vertical shield and the second generally planar vertical shield to protect the user's upper body from the radiation emanating from the radiation source.

13. The radiation assembly of claim 1 , wherein one or both of said shields have a radiopacity of at least 0.5 mm lead equivalent.

14. The radiation assembly of claim 1 , further comprising a third generally planar shield fastened to the first generally planar vertical shield.

15. The radiation assembly of claim 14 , wherein the third generally planar shield is translationally static with respect to the first generally planar vertical shield.

16. The radiation assembly of claim 1 , wherein both of said shields reduce radiation exposure to no more than about 2.5 mR/hr when measured by the Modified ASTM F3094/IEC 61131-1 Protocol.

17. A radiation shield assembly, configured to block radiation emanating from a radiation source from below a table for supporting a patient, the assembly comprising:

(a) a support arm configured to be suspended from overhead, the support arm configured to support about the entire weight of the shield assembly;

(b) a first generally planar vertical shield that has a radiopacity to X-rays of at least 0.5 mm lead equivalent;

(c) a second generally planar vertical shield that has a radiopacity to X-rays of at least 0.5 mm lead equivalent; and

(d) at least one of: (i) a first sterile covering on the first generally planar vertical shield; and (ii) a second sterile covering on the second shielding means;

wherein the first generally planar vertical shield is joined to the second generally planar vertical shield to form a radiopaque barrier;

wherein the radiation shield assembly is configured to allow at least one of the first generally planar vertical shield and the second generally planar vertical shield to be rotated relative to the other about an approximately vertical axis; and

wherein the radiation shield assembly is configured to position the first generally planar vertical shield and the second generally planar vertical shield to protect a user's upper body from radiation emanating from the radiation source.

18. A radiation shield assembly, configured to block radiation emanating from a radiation source below a table for supporting a patient, the assembly comprising:

(a) a supporting means to support the assembly, and configured to allow the assembly to translate relative to the table to provide access to the patient;

(b) a first shielding means to block radiation from the source in a first approximately vertical plane, fastened to the supporting means, and

(c) a second shielding means to block radiation from the source in a second approximately vertical plane, fastened to the supporting means to allow the second shielding means to translate and rotate along an approximately vertical axis relative to the first shielding means;

(d) at least one of: (i) a first sterile covering on the first shielding means, and (ii) a second sterile covering on the second shielding means;

wherein the support means is configured to position the assembly such that a bottom edge of the first shielding means is about at the surface of the table and that a top edge of the first shielding means is at least 175 cm (±20%) from the floor.

19. The radiation shield assembly of claim 18 , wherein the first and the second shielding means are configured to rotate relative to one another over an arc of from about 0-180°.

20. The radiation shield assembly of claim 18 , wherein the supporting means comprises an approximately vertical mast.

21. The radiation shield assembly of claim 18 , wherein in operation the supporting means supports the entire weight of the radiation shield assembly.

22. The radiation shield assembly of claim 18 , wherein at least one of the first and second shielding means has a radiopacity of least 0.5 mm lead equivalent.

23. The radiation shield assembly of claim 18 , wherein at least one of the first and second shielding means has a radiopacity of least 3 mm lead equivalent.

24. The radiation shield assembly of claim 18 , wherein at least one of the first and second shielding means reduce radiation exposure by at least 85% when measured by the Modified ASTM F3094/IEC 61331-1 Protocol.

25. The radiation shield assembly of claim 18 , wherein at least one of the first and second shielding means reduce radiation exposure to below 2.5 mR/hr when measured by the Modified ASTM F3094/IEC 61331-1 Protocol.

26. The radiation shield assembly of claim 18 , wherein the support means comprises a mast supported by a floor stand.

27. The radiation shield assembly of claim 18 , wherein the support means is a mast that is suspended by an overhead boom.

28. The radiation shield assembly of claim 18 , wherein the support means is configured to position the assembly such that a bottom edge of the first shielding means is about at the surface of the table and that a top edge of the first shielding means is at least about 190 (±20%) cm from the floor.

29. A radiation shield assembly, configured to block radiation emanating from a radiation source below a table for supporting a patient, the radiation shield assembly comprising:

(a) a first generally vertical shield supported by a support member; and

(b) a second generally vertical shield supported by the support member; wherein the first and the second generally vertical shields can be rotated relative to one another about an axis approximately parallel to a longitudinal axis of the support member; and

(d) at least one of: (i) a first sterile covering on the first generally vertical shield, and (ii) a second sterile covering on the second generally vertical shield;

wherein the first and the second generally vertical shields have a height of at least a distance from an upper surface of the table to 175 cm (±10%) from a floor.

30. The radiation shield assembly of claim 29 , wherein the first and the second generally vertical shields can be rotated relative to one another over an arc of at least about 90°.

31. The radiation shield assembly of claim 29 , wherein the support member is capable of supporting an entire weight of the radiation shield assembly.

32. The radiation shield assembly of claim 29 , wherein at least one of the first and second generally vertical shields has a radiopacity of least 0.5 mm lead equivalent.

33. The radiation shield assembly of claim 29 , wherein the first and the second generally vertical shields can be rotated relative to one another about the longitudinal axis of the support member.

34. The radiation shield assembly of claim 29 , wherein the support member is a mast that is suspended by an overhead boom.

35. The radiation shield assembly of claim 29 , wherein the support member is configured to be supported by a ceiling.

36. The radiation shield assembly of claim 29 , wherein the first generally vertical shield is fastened to the support member via a first radiopaque joint.

37. A radiation shield assembly, configured to block radiation emanating from a radiation source below a table for supporting a patient, the radiation shield assembly comprising:

(a) a first generally vertical shield supported by a support member;

(b) a second generally vertical shield supported by the support member; and

(d) at least one of: (i) a first sterile covering on the first generally vertical shield, and (ii) a second sterile covering on the second generally vertical shield;

wherein the first and the second generally vertical shields can be rotated relative to one another about an axis approximately parallel to a longitudinal axis of the support member;

and wherein the assembly is configured to position the first and the second generally vertical shields to protect a user's upper body from radiation emitted from said radiation source.

38. The radiation shield assembly of claim 37 , wherein the assembly is configured to position the first and the second generally vertical shields at least 175 cm (±20%) above a floor below the table.

39. The radiation shield assembly of claim 37 , wherein the first and the second generally vertical shields can be rotated relative to one another over an arc of at least 90°.

40. The radiation shield assembly of claim 37 , wherein the support member is capable of supporting an entire weight of the radiation shield assembly.

41. The radiation shield assembly of claim 37 , wherein at least one of the first and the second generally vertical shields has a radiopacity of least 0.5 mm lead equivalent.

42. The radiation shield assembly of claim 37 , wherein the first generally vertical shield is fastened to the support member via a first radiopaque joint.

43. The radiation shield assembly of claim 37 , wherein the support member is configured to be supported from overhead.

44. The radiation shield assembly of claim 37 , wherein the first and the second generally vertical shields can be rotated relative to one another about the longitudinal axis of the support member.

45. A radiation shield assembly, configured to block radiation emanating from a radiation source below a table for supporting a patient, the radiation shield assembly comprising:

(a) a first generally vertical shield supported by a support member;

(b) a second generally vertical shield supported by the support member; wherein the first and the second generally vertical shields can be rotated relative to one another about an axis approximately parallel to a longitudinal axis of the support member; and

(d) at least one of: (i) a first sterile covering on the first generally vertical shield, and (ii) a second sterile covering on the second generally vertical shield;

wherein the radiation shield assembly is configured to position the first and the second generally vertical shields to extend from about a surface of the table to a level effective to prevent direct radiation from said source from reaching a user's head.

46. The radiation shield assembly of claim 45 , wherein the first and the second generally vertical shields can be rotated relative to one another over an arc of at least 90°.

47. The radiation shield assembly of claim 45 , wherein the support member is capable of supporting an entire weight of the radiation shield assembly.

48. The radiation shield assembly of claim 45 , wherein at least one of the first and the second generally vertical shields has a radiopacity of least 0.5 mm lead equivalent.

49. The radiation shield assembly of claim 45 , wherein the support member is a mast that is suspended from overhead.

50. The radiation shield assembly of claim 45 , wherein the first generally vertical shield is fastened to the support member via a first radiopaque joint.

51. A radiography method comprising:

(a) positioning the radiation shield assembly of claim 1 between a patient and the user; and

(b) irradiating the patient using the radiation source positioned such that radiation passes at least partially through the patient while being blocked from reaching the user's upper body by the radiation shield assembly.

52. A radiography method comprising:

(a) positioning the radiation shield assembly of claim 17 between a patient and the user; and

(b) irradiating the patient using the radiation source positioned such that radiation passes at least partially through the patient while being blocked from reaching the user's upper body by the radiation shield assembly.

53. A radiography method comprising:

(a) positioning the radiation shield assembly of claim 18 between a patient and the user; and

(b) irradiating the patient using the radiation source positioned such that radiation passes at least partially through the patient while being blocked from reaching the user's upper body by the radiation shield assembly.

54. A radiography method comprising:

(a) positioning the radiation shield assembly of claim 29 between a patient and the user; and

(b) irradiating the patient using the radiation source positioned such that radiation passes at least partially through the patient while being blocked from reaching the user's upper body by the radiation shield assembly.

55. A radiography method comprising:

(a) positioning the radiation shield assembly of claim 37 between a patient and the user; and

(b) irradiating the patient using the radiation source positioned such that radiation passes at least partially through the patient while being blocked from reaching the user's upper body by the radiation shield assembly.

56. A radiography method comprising:

(a) positioning the radiation shield assembly of claim 45 between a patient and the user; and

(b) irradiating the patient using the radiation source positioned such that radiation passes at least partially through the patient while being blocked from reaching the user's upper body by the radiation shield assembly.

Assignments (3)
ENTITY CONVERSION Recorded Aug 7, 2025
From: RAMPART IC, LLC
To: RAMPART IC, INC.
Reel/Frame 072354/0111 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2022
From: INTERVENTION FOR LIFE, LLC
To: RAMPART IC, LLC
Reel/Frame 059503/0263 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: FOSTER, ROBERT EVANS; COOPER, LLOYD GUYTON BOWERS; LIVINGSTON, WILLIAM THOMAS; PHILLIPS, FOSTER D.
To: INTERVENTION FOR LIFE, LLC
Reel/Frame 058153/0649 →
Continuity (4)
Continuation 16083393
Provisional Application 62835943 · Apr 18, 2019
Provisional Application 62544468 · Aug 11, 2017
Related Publication 20220218295A1 · Jul 14, 2022
References Cited (106)
US 3984696A · Collica et al. · 1976 [cited by applicant]
US 4254341A · Herr et al. · 1981 [cited by applicant]
US 4280056A · Renshaw · 1981 [cited by applicant]
US 4581538A · Lenhart · 1986 [cited by applicant]
US D300945S · Fleming et al. · 1989 [cited by applicant]
US 4923162A · Fleming et al. · 1990 [cited by applicant]
US 4965456A · Huettenrauch et al. · 1990 [cited by applicant]
US 5006718A · Lenhart · 1991 [cited by applicant]
US 5015864A · Maleki · 1991 [cited by applicant]
US 5090044A · Kobayashi · 1992 [cited by applicant]
US 5417225A · Rubenstein et al. · 1995 [cited by applicant]
US 5981964A · McAuley et al. · 1999 [cited by applicant]
US 6325538B1 · Heesch · 2001 [cited by applicant]
US 6448571B1 · Goldstein · 2002 [cited by applicant]
US 6703632B1 · Macklis et al. · 2004 [cited by applicant]
US 7276716B1 · Munro, III · 2007 [cited by applicant]
US 7331712B2 · Fischer et al. · 2008 [cited by applicant]
US 7391042B2 · Goldstein · 2008 [cited by applicant]
US 7465947B2 · Magram · 2008 [cited by applicant]
US 7608847B2 · Rees · 2009 [cited by applicant]
US 7638784B2 · Fox et al. · 2009 [cited by applicant]
US 7829873B2 · Fox et al. · 2010 [cited by applicant]
US 7973299B2 · Rees · 2011 [cited by applicant]
US 8143607B2 · Teodorescu · 2012 [cited by applicant]
US 8378326B2 · Hunt · 2013 [cited by applicant]
US 8399871B2 · Beyar et al. · 2013 [cited by applicant]
US 8439564B2 · Belson et al. · 2013 [cited by applicant]
US 8598554B2 · Rees · 2013 [cited by applicant]
US 8683928B2 · Anderson · 2014 [cited by applicant]
US 8716687B2 · Goldstein et al. · 2014 [cited by applicant]
US 9349492B1 · Ganus · 2016 [cited by applicant]
US D772414S · Ballsieper · 2016 [cited by applicant]
US 9877688B1 · Colling · 2018 [cited by applicant]
US 10441231B2 · Wilson et al. · 2019 [cited by applicant]
US 11045155B2 · Lemer · 2021 [cited by applicant]
US 11191495B2 · Wilson et al. · 2021 [cited by applicant]
US 11207039B2 · Foster et al. · 2021 [cited by applicant]
US 11666290B2 · Wilson et al. · 2023 [cited by applicant]
US 12053312B2 · Wilson et al. · 2024 [cited by applicant]
US 20040045557A1 · Lee et al. · 2004 [cited by applicant]
US 20070252095A1 · Magram · 2007 [cited by applicant]
US 20100319713A1 · Byers et al. · 2010 [cited by applicant]
US 20110174997A1 · Rees · 2011 [cited by applicant]
US 20120049093A1 · Costea · 2012 [cited by applicant]
US 20120132217A1 · Rees · 2012 [cited by applicant]
US 20120241652A1 · Jeschke · 2012 [cited by applicant]
US 20120256092A1 · Zingerman · 2012 [cited by applicant]
US 20130320246A1 · Beck · 2013 [cited by applicant]
US 20140048730A1 · Niedzielski et al. · 2014 [cited by applicant]
US 20150272519A1 · Buchmeyer · 2015 [cited by applicant]
US 20150335297A1 · Mogul et al. · 2015 [cited by applicant]
US 20160027540A1 · Gordon et al. · 2016 [cited by applicant]
US 20160029980A1 · Osherov et al. · 2016 [cited by applicant]
US 20160038365A1 · Conner et al. · 2016 [cited by applicant]
US 20160220199A1 · Gordon · 2016 [cited by applicant]
US 20170119324A1 · Wilson et al. · 2017 [cited by applicant]
US 20190063665A1 · LeCote · 2019 [cited by applicant]
US 20220071576A1 · Foster et al. · 2022 [cited by applicant]
US 20220243864A1 · Foster et al. · 2022 [cited by applicant]
DE 102014215448B3 · 2015 [cited by applicant]
JP 2001120543A · 2001 [cited by applicant]
JP 2009541712A · 2009 [cited by applicant]
JP 2010230311A · 2010 [cited by applicant]
KR 101081895 · 2011 [cited by applicant]
KR 101913840B1 · 2018 [cited by applicant]
WO 2018109380A1 · 2018 [cited by applicant]
WO 2019216934A2 · 2019 [cited by applicant]
WO 2020163773A1 · 2020 [cited by applicant]
WO 2020214992A1 · 2020 [cited by applicant]
Office Action received for European Patent Application No. 18908271.2, mailed on Nov. 29, 2023, 05 pages. [cited by applicant]
Notice of Refusal for Japanese Patent Application No. 2021-561838, mailed Nov. 17, 2023, 10 Pages including English Translation. [cited by applicant]
Examination Report received for Australian Patent Application No. 2018422761, mailed on May 15, 2023, 04 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Jul. 21, 2023, 04 pages. [cited by applicant]
Office Action received for European Patent Application No. 18908271.2, mailed on May 9, 2022, 05 pages. [cited by applicant]
First Office Action received for Japanese Patent Application No. 2020-530444, mailed on Jun. 21, 2022, 14 pages including English translation. [cited by applicant]
Second Office Action received for Japanese Patent Application No. 2020-530444, mailed on Nov. 24, 2022, 14 pages including English translation. [cited by applicant]
Decision of Dismissal of Amendment received for Japanese Patent Application No. 2020-530444, mailed on Apr. 25, 2023, 15 pages including English translation. [cited by applicant]
International Preliminary Report on Patentability received for International Patent Application No. PCT/US2018/046318, mailed on Feb. 20, 2022, 10 pages. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2018/046318, mailed on Nov. 12, 2019, 13 pages. [cited by applicant]
International Preliminary Report on Patentability received for International Patent Application No. PCT/US2020/028825, mailed on Oct. 28, 2021, 08 pages. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2020/028825, mailed on Aug. 5, 2020, 10 pages. [cited by applicant]
Search Report received for Japanese Patent Application No. 2020-530444, mailed on Jun. 15, 2022, 24 pages including English translation. [cited by applicant]
Search Report & Written Opinion received for Singapore patent Application No. 11202108590W, Completed on Apr. 21, 2023, 11 pages. [cited by applicant]
International Preliminary Report on Patentability received for International Application No. PCT/US2020/017309, mailed on Aug. 19, 2021, 10 pages. [cited by applicant]
First Substantive Examination Report received for Saudi Arabia Application No. 521422707, mailed on Jun. 24, 2023, 18 pages including English translation. [cited by applicant]
Office Action received for Indian patent Application No. 202147040405, mailed on Apr. 18, 2023, 10 pages. [cited by applicant]
ASTM F3094 (ASTM International “Standard Test Method for Determining Protection Provided by X-ray Shielding Garments Used in Medical X-ray Fluoroscopy from Sources of Scattered X-Rays” ASTM vol. 11.03 Occupational Healt… [cited by applicant]
IEC 61331-1 (International Electrotechnical Commission, “Protective devices against diagnostic medical X-radiation—Part 1: Determination of attenuation properties of materials” (2014). [cited by applicant]
Aadco Medical, Inc. “Overhead Barriers” obtained from world wide web Dec. 29, 2016; http://www.aadcbmed.com/products/barriers_shields/overhead_barriers; pp. 1-4. [cited by applicant]
Kenex Co. Lower body x-ray shield 312/E-010; obtained from world wide web Dec. 29, 2016; http://kenex.co.uk/products/x-ray-shielding/x-ray-table-mounted-shields/lower-body-x-ray . . . ; pp. 1-3. [cited by applicant]
Kenex Co. “Overhead ceiling mounted shield 350” obtained from world wide web Dec. 29, 2016; http://kenex.co.uk/products/x-ray-shielding/overhead-suspended-shields-lamps/overhead . . . ; pp. 1-3. [cited by applicant]
Fattal, Peter et al. “A Novel Complete Radiation Protection System Eliminates Physician Radiation Exposure and Leaded Aprons” Catheterization and Cardiovascular Interventions 81:11-16 (2013) pp. 1-6. [cited by applicant]
De La Hera, German “International Search Report and Written Opinion—International Application No. PCT/US2020/017309” Apr. 20, 2020; pp. 1-15. [cited by applicant]
Strubel, Christine “International Preliminary Report on Patentability and Written Opinion” European Patent Office; Feb. 11, 2020; pp. 1-9. [cited by applicant]
Extended European Search Report received for European Patent Application No. 23196608.6, mailed on Dec. 11, 2023, 09 pages. [cited by applicant]
Office Action received for European Patent Application No. 20725007.7, mailed on Mar. 1, 2024, 4 Pages. [cited by applicant]
Office Action received for Australian Patent Application No. 2018422761, mailed on Jan. 29, 2024, 03 pages. [cited by applicant]
Office Action received for Australian Patent Application No. 2018422761, mailed on Feb. 12, 2024, 02 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Feb. 7, 2024, 03 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3129066, mailed on Jan. 22, 2024, 04 pages. [cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Jan. 15, 2024, 6 Pages. [cited by applicant]
Notice of Refusal for Japanese Patent Application No. 2021-545836, mailed Mar. 28, 2024, 10 Pages including English Translation. [cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Aug. 2, 2024, 05 pages. [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2021-561838, mailed May 9, 2024, 06 Pages including English Translation. [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2023-137479, mailed Apr. 30, 2024, 15 Pages including English Translation. [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2023-137479, mailed Aug. 8, 2024, 06 Pages including English Translation. [cited by applicant]